16.72
price up icon1.09%   0.18
after-market Handel nachbörslich: 16.72
loading
Schlusskurs vom Vortag:
$16.54
Offen:
$16.54
24-Stunden-Volumen:
543.37K
Relative Volume:
1.18
Marktkapitalisierung:
$482.75M
Einnahmen:
$219.79M
Nettoeinkommen (Verlust:
$-57.47M
KGV:
-7.7767
EPS:
-2.15
Netto-Cashflow:
$-19.25M
1W Leistung:
-14.26%
1M Leistung:
-9.72%
6M Leistung:
-37.43%
1J Leistung:
-16.06%
1-Tages-Spanne:
Value
$16.25
$16.95
1-Wochen-Bereich:
Value
$16.25
$19.70
52-Wochen-Spanne:
Value
$15.45
$35.84

Castle Biosciences Inc Stock (CSTL) Company Profile

Name
Firmenname
Castle Biosciences Inc
Name
Telefon
866-788-9007
Name
Adresse
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Name
Mitarbeiter
784
Name
Twitter
@castlebio
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
CSTL's Discussions on Twitter

Vergleichen Sie CSTL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
CSTL
Castle Biosciences Inc
16.72 563.01M 219.79M -57.47M -19.25M -2.15
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
404.94 160.56B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
188.07 141.52B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
520.87 42.74B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
112.04 34.11B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
158.96 27.70B 15.50B 1.33B 2.16B 7.34

Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-12-14 Eingeleitet Guggenheim Buy
2023-01-05 Eingeleitet Scotiabank Sector Outperform
2022-01-07 Eingeleitet Stephens Overweight
2021-04-30 Eingeleitet Lake Street Buy
2020-11-10 Eingeleitet KeyBanc Capital Markets Overweight
2019-12-27 Bestätigt Canaccord Genuity Buy
2019-08-19 Eingeleitet BTIG Research Buy
2019-08-19 Eingeleitet Canaccord Genuity Buy
2019-08-19 Eingeleitet Robert W. Baird Outperform
2019-08-19 Eingeleitet SVB Leerink Outperform
Alle ansehen

Castle Biosciences Inc Aktie (CSTL) Neueste Nachrichten

pulisher
Jul 21, 2025

Teacher Retirement System of Texas Grows Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 21, 2025
pulisher
Jul 21, 2025

Stephens Inc. AR Has $273,000 Stake in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

Castle Biosciences Inc. Stock Analysis and ForecastBreakneck growth rates - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Castle Biosciences Inc. stock priceFree Trading Strategy Suggestions - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about Castle Biosciences Inc. stockFree Investment Case Studies - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 18, 2025

Is Castle Biosciences Inc. a good long term investmentHigh-yield trading alerts - Jammu Links News

Jul 18, 2025
pulisher
Jul 17, 2025

Castle Biosciences Achieves Multiple Awards Recognizing Workplace Excellence in 2025 Top Workplaces Program - Quiver Quantitative

Jul 17, 2025
pulisher
Jul 17, 2025

Castle Biosciences earns multiple Top Workplaces awards, including national Healthcare Industry award. - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Castle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company’s Strong Culture - GlobeNewswire

Jul 17, 2025
pulisher
Jul 17, 2025

Castle Biosciences Dominates Healthcare Workplace Rankings with 7 Major Awards and #3 Industry Position - Stock Titan

Jul 17, 2025
pulisher
Jul 16, 2025

How Castle Biosciences Inc. stock performs during market volatilityTop Rated Trade Entries - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

Castle Biosciences to Release Q2 2025 Financial Results and Host Conference Call on Aug. 4 - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

Why Castle Biosciences Inc. stock attracts strong analyst attentionEarly Buy Suggestion - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Castle Biosciences Inc. stock price move sharplyProven Trading Plan - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Castle Biosciences' Q2 Results: Diagnostic Innovation Fuels Growth Amid Profit Challenges - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

Castle Biosciences, Inc. to Release Second Quarter Financial Results on August 4, 2025 - Nasdaq

Jul 14, 2025
pulisher
Jul 14, 2025

Castle Biosciences to Release Second Quarter 2025 Financial - GlobeNewswire

Jul 14, 2025
pulisher
Jul 14, 2025

Castle Biosciences Sets Q2 2025 Earnings Date: Key Financial Results Coming August 4 - Stock Titan

Jul 14, 2025
pulisher
Jul 07, 2025

Allspring Global Investments Holdings LLC Raises Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 07, 2025
pulisher
Jun 30, 2025

Castle Biosciences, Inc.(NasdaqGM: CSTL) dropped from Russell 2500 Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 28, 2025

Is Castle Biosciences (NASDAQ:CSTL) Using Too Much Debt? - 富途牛牛

Jun 28, 2025
pulisher
Jun 25, 2025

GAMMA Investing LLC Purchases 4,142 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 25, 2025
pulisher
Jun 25, 2025

Castle Biosciences partners with SciBase for diagnostic tests - MSN

Jun 25, 2025
pulisher
Jun 19, 2025

Castle Biosciences Awards Major RSU Package: 135,978 Shares with 4-Year Vesting for Employee Retention - Stock Titan

Jun 19, 2025
pulisher
Jun 17, 2025

Castle Biosciences Inc (CSTL) Stock Price Down 4.54% on Jun 17 - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Castle Biosciences partners with SciBase to develop atopic dermatitis test - Investing.com India

Jun 17, 2025
pulisher
Jun 16, 2025

Castle Biosciences, SciBase Partner to Develop Predictive Tests for Skin Conditions - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences partners with SciBase for diagnostic tests (CSTL) - Seeking Alpha

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences partners with SciBase to develop atopic dermatitis test By Investing.com - Investing.com Nigeria

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences (CSTL) Partners with SciBase for Dermatology Advancements | CSTL Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences enters collaboration, license agreement with Scibase to develop diagnostic tests for dermatologic diseases - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

SciBase resolves on a directed share issue of SEK 19 million and announces its intention to carry out an additional directed share issue of approximately SEK 11 million - Yahoo Finance

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences Enters Collaboration and License Agreement wi - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

SciBase signs license agreement with Castle Biosciences to develop dermatology diagnostic tests - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases - The Manila Times

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences Enters Collaboration and License - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

New Diagnostic Test Could Predict Atopic Dermatitis Flares Before Symptoms Appear - Stock Titan

Jun 16, 2025
pulisher
Jun 15, 2025

Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Sold by Harbor Capital Advisors Inc. - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards® - Barchart.com

Jun 14, 2025
pulisher
Jun 11, 2025

Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention | CSTL Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences’ Chief Executive Officer Derek Maetzold - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences’ Chief Executive Officer Derek Maetzold to Participate in Panel Discussion ... - Bluefield Daily Telegraph

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences’ Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - Barchart.com

Jun 11, 2025
pulisher
Jun 08, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Two Sigma Advisers LP Acquires New Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Squarepoint Ops LLC Lowers Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Castle Biosciences' Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards® - The Manila Times

Jun 04, 2025
pulisher
Jun 04, 2025

Castle Biosciences’ Founder, President and CEO Derek - GlobeNewswire

Jun 04, 2025
pulisher
Jun 01, 2025

ProShare Advisors LLC Makes New $230,000 Investment in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 01, 2025

Finanzdaten der Castle Biosciences Inc-Aktie (CSTL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research WAT
$281.66
price down icon 2.04%
diagnostics_research DGX
$166.45
price down icon 0.28%
$140.63
price up icon 1.25%
diagnostics_research LH
$243.04
price down icon 0.28%
diagnostics_research MTD
$1,166.48
price down icon 2.37%
diagnostics_research IQV
$158.96
price down icon 1.04%
Kapitalisierung:     |  Volumen (24h):